Stunning Announcement: Ultra-Miniature Brain-Machine Interface, Achieving a 91% Accuracy in Thought-to-Text Translation
Release time:
2024-10-12
In the burgeoning field of brain-machine interfaces (BMI), Elon Musk and his Neuralink are undoubtedly the stars. However, today we unveil a rising star from the École Polytechnique Fédérale de Lausanne (EPFL) in Switzerland—the Micro Brain-Machine Interface (MiBMI), which embodies the essence of "small size, big power"!
Revolutionary Breakthrough, Ultra-Compact Size
Imagine a BMI chip so small that it is only the size of two 8-square millimeter thin sheets combined, practically negligible in dimension, yet containing unprecedented technological power. Compared to Neuralink's slightly larger 23x8 millimeter form, MiBMI seems like a miniature robot from a sci-fi movie, seamlessly navigating the neural networks of the brain and performing miraculous tasks quietly.
Low Power, High Efficiency, Minimally Invasive
Even more astonishing is that the MiBMI, while compact, boasts ultra-low power consumption and minimal invasiveness. It features a complete real-time data processing system built-in, capable of independently transforming brain signals into text without the need for bulky external devices. In contrast, Neuralink's 64 electrodes penetrate the brain and require auxiliary external equipment, making it appear somewhat cumbersome and complex.
Accurate Decoding, Seamless Thought-to-Text Interface
Through relentless effort, EPFL scientists have uncovered the "neural code" (DNC) hidden deep within the brain. These unique neural markers act as the brain's secret language, subtly activating whenever people imagine writing letters. MiBMI captures these subtle signals and translates them accurately into text on the screen, achieving an impressive 91% accuracy!
The Future is Here, Boundless Communication
The potential of this technology stretches far beyond its current capabilities. Presently, MiBMI can decode 31 characters, but the research team asserts this is just the tip of the iceberg. They are confident that soon this system will unlock up to 100 characters, opening a new door of communication for patients with severe motor impairments. Imagine those who have lost their voices due to illness being able to communicate directly with the world through their thoughts—how exhilarating!
In this rapidly advancing technological era, the emergence of MiBMI undoubtedly paints a grand blueprint for future medicine. It symbolizes not only technological progress but also the crystallization of human wisdom and courage. Let us collectively look forward to the day when this technology moves out of the laboratory to truly benefit everyone in need!
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155515
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
